| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 192.34B | 166.85B | 194.75B | 167.03B | 170.63B | 156.77B |
| Gross Profit | 32.01B | 30.06B | 29.85B | 30.44B | 33.10B | 27.77B |
| EBITDA | 10.76B | 12.55B | 16.23B | 11.39B | 10.08B | 6.53B |
| Net Income | 5.58B | 7.12B | 8.96B | 6.36B | 3.83B | 3.14B |
Balance Sheet | ||||||
| Total Assets | 65.28B | 63.47B | 66.35B | 68.46B | 71.63B | 64.11B |
| Cash, Cash Equivalents and Short-Term Investments | 31.00B | 29.51B | 31.71B | 29.32B | 31.97B | 25.83B |
| Total Debt | 12.09B | 9.86B | 7.91B | 12.29B | 16.42B | 19.91B |
| Total Liabilities | 32.58B | 31.33B | 30.02B | 34.01B | 41.70B | 42.87B |
| Stockholders Equity | 31.35B | 30.79B | 34.99B | 33.23B | 28.91B | 20.35B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.55B | 5.62B | 3.95B | 12.94B | 2.23B |
| Operating Cash Flow | 0.00 | 7.60B | 5.68B | 3.99B | 13.00B | 2.28B |
| Investing Cash Flow | 0.00 | -331.00M | 5.87B | -210.00M | -2.14B | -6.30B |
| Financing Cash Flow | 0.00 | -9.47B | -9.14B | -6.43B | -4.75B | 4.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥14.72T | 30.04 | 27.29% | 0.27% | 3.93% | 29.13% | |
74 Outperform | ¥231.28B | 15.52 | 28.98% | 5.57% | 3.47% | 18.14% | |
69 Neutral | ¥107.61B | 13.95 | ― | 7.51% | -14.32% | -17.67% | |
69 Neutral | ¥522.63B | 12.15 | 19.18% | 3.59% | 7.21% | 20.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
42 Neutral | ¥56.32B | -12.49 | -6.02% | 0.77% | -3.21% | -104.97% |